Understanding how screening and treating asymptomatic malaria can help control the disease
Quantifying the potential contribution of asymptomatic screening and treatment to malaria control and elimination
This study is looking at how checking for and treating malaria in people who don’t have symptoms could help stop the disease from spreading, and it’s designed for anyone interested in improving malaria control in their community.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10892856 on NIH RePORTER |
What this research studies
This research investigates the role of screening and treating individuals who do not show symptoms of malaria in reducing the spread of the disease. By using data from a previous clinical trial in Burkina Faso, the study aims to create a detailed model that predicts how effective these interventions could be if implemented widely. The approach involves agent-based modeling to simulate the impact of regular screening and treatment on malaria transmission and population health outcomes. Patients may be involved in the screening process or benefit from improved malaria control measures resulting from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals living in malaria-endemic regions, particularly in Sub-Saharan Africa.
Not a fit: Patients who do not reside in malaria-endemic areas or those who are already symptomatic may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for controlling and potentially eliminating malaria, ultimately saving lives.
How similar studies have performed: Preliminary results from similar studies have shown promise, indicating that screening and treatment can significantly reduce malaria transmission.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Holden, Tobias — Northwestern University at Chicago
- Study coordinator: Holden, Tobias
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.